Corapcioglu, F. Et Al. 2008. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.. Pediatric hematology and oncology , vol.25, no.6 , 509-21.

Corapcioglu, F., Aksu, G., Basar, E. Z., Demirel, A., Oncel, S., & Mutlu, A., (2008). Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.. Pediatric hematology and oncology , vol.25, no.6, 509-21.

Corapcioglu, F Et Al. "Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.," Pediatric hematology and oncology , vol.25, no.6, 509-21, 2008

Corapcioglu, F Et Al. "Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.." Pediatric hematology and oncology , vol.25, no.6, pp.509-21, 2008

Corapcioglu, F. Et Al. (2008) . "Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.." Pediatric hematology and oncology , vol.25, no.6, pp.509-21.

@article{article, author={F Corapcioglu Et Al. }, title={Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.}, journal={Pediatric hematology and oncology}, year=2008, pages={509-21} }